Previous 10 | Next 10 |
Ireland-based Icon ( NASDAQ: ICLR ) on Thursday said it had been selected by the U.S. Biomedical Advanced Research and Development Authority (BARDA) to conduct a clinical trial evaluating a vaccine for anthrax. "BARDA is providing funding to the Government and Public Healt...
ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announces that it has been selected by the US Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Respons...
Summary BAMCO’s 13F portfolio value decreased from $40.75B to $31.14B this quarter. Ron Baron increased SiteOne Landscape, ASGN, and Floor & Décor Holdings while reducing Taiwan Semi, Marriott Vacations Worldwide, and PENN Entertainment. Their top five position...
Summary West Pharmaceutical Services is a quality firm that is doing well right now. But this doesn't make the firm an attractive prospect, even if we assume that management's forecast for 2022 is accurate. Shares need to get cheaper if the business is to make for a compelling...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organisation, today announced that it will release its financial results for the third quarter 2022 after the market closes on Wednesday, November 2, 2022. The company will hold a conference c...
Summary A high level of restructuring is occurring with the Healthcare industry’s largest constituents. Most restructuring is taking the form of splits or spin-offs, but not all incidences look beneficial. This article will summarize coming transactions and provide comm...
ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today releases its 2021 Environmental, Social and Governance (ESG) Report . The report outlines how ICON is delivering on its ESG commitments and measured its performance in...
ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the 2022 Wells Fargo Healthcare Conference on Wednesday, September 7, 2022. The presentation will be webca...
Summary Mettler-Toledo International has done really well in growing its top and bottom lines in recent years, and that trend is very likely to continue. Overall, the company is a great operator in its space, but this doesn't make it a great investment prospect today. Given ho...
Waters Corporation has continued to grow its top line, but some bottom line results have been weak. Fortunately, the picture for the year as a whole continues to look up and the firm's long-term outlook will probably be positive. But shares do not make for an attractive purchase a...
News, Short Squeeze, Breakout and More Instantly...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the second quarter 2024 after the market closes on Wednesday, July 24, 2024. The company will hold a conference call and webcas...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 1:30pm ET. Any changes to this event and links...
2024-05-31 07:00:07 ET David Windley from Jefferies issued a price target of $390.00 for ICLR on 2024-05-31 05:48:00. The adjusted price target was set to $390.00. At the time of the announcement, ICLR was trading at $322.92. The overall price target consensus is at $265...